184 related articles for article (PubMed ID: 16645008)
41. [Current TSH-sensitive assays simplify thyroid diagnosis].
Gerber H; Peter HJ; Koechli HP
Schweiz Med Wochenschr; 1987 Oct; 117(41):1565-70. PubMed ID: 3313695
[TBL] [Abstract][Full Text] [Related]
42. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
[TBL] [Abstract][Full Text] [Related]
43. Utility of third generation thyrotropin assays in thyroid function testing.
Saller B; Broda N; Heydarian R; Görges R; Mann K
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 4():S29-33. PubMed ID: 9867193
[TBL] [Abstract][Full Text] [Related]
44. [Is there a need for treatment in subclinical hypo- and hyperthyroidism?].
Lerch M; Meier C; Staub JJ
Ther Umsch; 1999 Jul; 56(7):369-73. PubMed ID: 10434773
[TBL] [Abstract][Full Text] [Related]
45. The TSH upper reference limit: where are we at?
Laurberg P; Andersen S; Carlé A; Karmisholt J; Knudsen N; Pedersen IB
Nat Rev Endocrinol; 2011 Apr; 7(4):232-9. PubMed ID: 21301488
[TBL] [Abstract][Full Text] [Related]
46. Reference intervals in evaluation of maternal thyroid function during the first trimester of pregnancy.
Springer D; Zima T; Limanova Z
Eur J Endocrinol; 2009 May; 160(5):791-7. PubMed ID: 19228824
[TBL] [Abstract][Full Text] [Related]
47. Reference intervals for serum thyrotropin: dependence on the population investigated.
Szabolcs I; Ploenes C; Beyer M; Bernard W; Herrmann J
Exp Clin Endocrinol; 1991; 98(1):23-31. PubMed ID: 1936143
[TBL] [Abstract][Full Text] [Related]
48. Universal screening detects two-times more thyroid disorders in early pregnancy than targeted high-risk case finding.
Horacek J; Spitalnikova S; Dlabalova B; Malirova E; Vizda J; Svilias I; Cepkova J; Mc Grath C; Maly J
Eur J Endocrinol; 2010 Oct; 163(4):645-50. PubMed ID: 20682632
[TBL] [Abstract][Full Text] [Related]
49. Application of an immunoradiometric assay for thyrotrophin in evaluation of thyroidal and nonthyroidal disease states.
McLellan GH; Riley WJ; Summers MB; Sudholz P; Hickman PE
Pathology; 1987 Jul; 19(3):229-32. PubMed ID: 3431910
[TBL] [Abstract][Full Text] [Related]
50. The effect of thyroid antibody positivity on reference intervals for thyroid stimulating hormone (TSH) and free thyroxine (FT4) in an aged population.
Eskelinen S; Suominen P; Vahlberg T; Löppönen M; Isoaho R; Kivelä SL; Irjala K
Clin Chem Lab Med; 2005; 43(12):1380-5. PubMed ID: 16309377
[TBL] [Abstract][Full Text] [Related]
51. Thyroid function from birth to adolescence in Prader-Willi syndrome.
Sharkia M; Michaud S; Berthier MT; Giguère Y; Stewart L; Deladoëy J; Deal C; Van Vliet G; Chanoine JP
J Pediatr; 2013 Sep; 163(3):800-5. PubMed ID: 23623517
[TBL] [Abstract][Full Text] [Related]
52. The use and limitations of a chemiluminescent thyrotropin assay as a single thyroid function test in an out-patient endocrine clinic.
Ross DS; Daniels GH; Gouveia D
J Clin Endocrinol Metab; 1990 Sep; 71(3):764-9. PubMed ID: 2394778
[TBL] [Abstract][Full Text] [Related]
53. Five-year thyrotropin screening for congenital hypothyroidism in Ramathibodi Hospital.
Mahachoklertwattana P; Phuapradit W; Siripoonya P; Charoenpol O; Thuvasethakul P; Rajatanavin R
J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S27-32. PubMed ID: 10730514
[TBL] [Abstract][Full Text] [Related]
54. [Evaluation of TSH suppression using a 3d-generation TSH assay: diagnostic and therapeutic consequences].
Exer P; Staub JJ; Zulewski H; Müller B; Kunz M; Huber P
Schweiz Med Wochenschr; 1992 Dec; 122(51-52):1964-7. PubMed ID: 1475661
[TBL] [Abstract][Full Text] [Related]
55. Subclinical thyroid dysfunction and blood pressure: a community-based study.
Walsh JP; Bremner AP; Bulsara MK; O'Leary P; Leedman PJ; Feddema P; Michelangeli V
Clin Endocrinol (Oxf); 2006 Oct; 65(4):486-91. PubMed ID: 16984241
[TBL] [Abstract][Full Text] [Related]
56. The clinical significance of subclinical thyroid dysfunction.
Biondi B; Cooper DS
Endocr Rev; 2008 Feb; 29(1):76-131. PubMed ID: 17991805
[TBL] [Abstract][Full Text] [Related]
57. Serum thyrotropin is a better predictor of future thyroid dysfunction than thyroid autoantibody status in biochemically euthyroid patients with diabetes: implications for screening.
Warren RE; Perros P; Nyirenda MJ; Frier BM
Thyroid; 2004 Oct; 14(10):853-7. PubMed ID: 15588383
[TBL] [Abstract][Full Text] [Related]
58. Linking medical needs and performance goals: clinical and laboratory perspectives on thyroid disease.
Hay ID; Klee GG
Clin Chem; 1993 Jul; 39(7):1519-24. PubMed ID: 8330414
[TBL] [Abstract][Full Text] [Related]
59. Composite reference interval for thyroid-stimulating hormone and free thyroxine, comparison with common cutoff values, and reconsideration of subclinical thyroid disease.
Ross HA; den Heijer M; Hermus AR; Sweep FC
Clin Chem; 2009 Nov; 55(11):2019-25. PubMed ID: 19713278
[TBL] [Abstract][Full Text] [Related]
60. The thyroid--too much and too little across the ages. The consequences of subclinical thyroid dysfunction.
Franklyn JA
Clin Endocrinol (Oxf); 2013 Jan; 78(1):1-8. PubMed ID: 22891671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
